Amniotic Fluid: The Use of High-Dimensional Biology to Understand Fetal Well-Being. (January 2014)

• Record Type: Journal Article
• Authors: Kamath-Rayne, Beena D.; Smith, Heather C.; Muglia, Louis J.; Morrow, Ardythe L.
• Is Part Of: Reproductive sciences. Volume 21:Number 1(2014:Jan.)
• Page Start: 6
• Page End: 19
• Publication Date: 2014-01
• Subjects: amniotic fluid -- systems biology -- proteomics -- transcriptomics -- preterm birth; Reproductive health -- Periodicals; Reproduction -- Periodicals; 612.6
• DOI: 10.1177/1933719113485292
• Languages: English
• ISSNs: 1933-7191

Abstract

Our aim was to review the use of high-dimensional biology techniques, specifically transcriptomics, proteomics, and metabolomics, in amniotic fluid to elucidate the mechanisms behind preterm birth or assessment of fetal development. We performed a comprehensive MEDLINE literature search on the use of transcriptomic, proteomic, and metabolomic technologies for amniotic fluid analysis. All abstracts were reviewed for pertinence to preterm birth or fetal maturation in human subjects. Nineteen articles qualified for inclusion. Most articles described the discovery of biomarker candidates, but few larger, multicenter replication or validation studies have been done. We conclude that the use of high-dimensional systems biology techniques to analyze amniotic fluid has significant potential to elucidate the mechanisms of preterm birth and fetal maturation. However, further multicenter collaborative efforts are needed to replicate and validate candidate biomarkers before they can become useful tools for clinical practice. Ideally, amniotic fluid biomarkers should be translated to a noninvasive test performed in maternal serum or urine.